Recombinant 2019-nCoV’s N-terminal Spike S1 RBD (319-541) fused to Nucleocapsid (237-419) protein with a linker HSA (human serum albumin) was expressed in CHO cells using a C-terminal His tag.
|
C19NSD-G242H |
|
|
50 ug
100 ug
|
|
|
$ 465 |
|
*The image is illustrative and does not necessarily represent the product
Overview:
The severe acute respiratory syndrome-related novel coronavirus SARS-CoV-2 has caused the pandemic of the respiratory diseases (COVID-19) around the world in 2020 (1). The spike glycoprotein (S) of coronavirus belongs to the type I transmembrane protein containing two subunits, S1 and S2 (2), which is also known to be the key component to bind with host cells through the interaction with angiotensin-converting enzyme 2 (ACE2) (3). N-protein is a potent antigen that provides the basis for future vaccine and diagnostic kit development (4).
Gene Aliases:
2019-nCoV S1, SARS-CoV-2 spike S1, SARS-CoV-2 S1, novel coronavirus spike s1, nCov spike s1, coronavirus spike S1; Nucleoprotein, Nucleocapsid protein, NC, Protein N
Genebank Number:
Formulation:
Recombinant protein stored in 1X PBS, pH 7.4
References:
1. Zhou P, et al: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-89.
2. Xiao X, et al: The SARS-CoV S glycoprotein. Cell Mol Life Sci. 2004, 61 (19-20): 2428-30.
3. Lan J, et al: Crystal structure of the 2019-nCov spike receptor-binding domain bound with the ACE2 receptor. bioRxiv. doi: https://doi.org/10.1101/2020.02.19.956235.
4. McBride R, et al: The coronavirus nucleocapsid is a multifunc-tional protein. Viruses. 2014, 6:2991-3018.
There are no related publications available for this product.
Acute Respiratory Distress Syndrome , Cardiovascular Disease, Cell Cycle, Cellular Stress, COVID19, Gastrointestinal Diseases , Infectious Diseases , Inflammation, Lung Diseases , Metabolic Disorder, Neurobiology, severe acute respiratory syndrome coronavirus 2 , Virology
2019-nCoV 3CLpro, Active , C19CL-G241H